The genetic testing company is reducing costs to improve margins.
Fool.com contributor Parkev Tatevosian considers Invitae (NVTA +0.00%) stock and its financial prospects to determine if investors should buy the stock.
*Stock prices used were the afternoon prices of Sept. 18, 2023. The video was published on Sept. 20, 2023.
*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
